1-10 of 10 results for subject:MRSA
Librarians' tools
- Search time
- 0.156 seconds
- Solr query time
- 0.004 seconds
- Search query
- subject:MRSA
- We searched for
- subject_t:MRSA OR subject_t:"Methicillin resistant staphylococcus aureus" OR subject_ses:11632
Member
X
Mike Hancock
Type
House
Session
Year
Department
Member
More
Hancock, Mike (10)
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health (1) whether personal anti-microbial products are supplied by the NHS to patients identified through screening to be carrying MRSA;
To ask the Secretary of State for Health (1) whether personal anti-microbial products are supplied by the NHS to patients identified through screening to be carrying MRSA;
Asked by
Mike Hancock
(Liberal Democrat)
Answered by
Ann Keen
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
17 April 2009
For answer on
21 April 2009
Answered on
23 April 2009
As soon as a patient is identified as an MRSA (methicillin-resistant Staphylococcus aureus) carrier, a decolonisation regimen should be started. This is normally the use of an antibacterial shampoo and body wash daily, and the application of an antibacterial nasal cream three times a day for five days supplied by the national health service.It is for clinicians to decide on the most appropriate products for decolonisation and we do not collect information on the products used. However, the Department will be issuing guidance on products for decontamination later this year.The current policy is to screen all elective patients, except for those in certain groups for whom the risk of MRSA infection is very low. We estimated that this would require around 6.3 million tests in 2009-10. Elective patients found to be positive for MRSA will receive decolonisation treatment. The total cost of screening those patients, and decolonising those with a positive screen, is estimated at £44 million, an average of £7.02 per patient.
Subjects
MRSA; Antimicrobials
Date
23 April 2009
Reference
491 c835-6W; 269985
House
House of Commons
(2) what steps he expects NHS hospitals to take to decolonise patients found through screening to be carrying MRSA; and if he will make a statement;
(2) what steps he expects NHS hospitals to take to decolonise patients found through screening to be carrying MRSA; and if he will make a statement;
Asked by
Mike Hancock
(Liberal Democrat)
Answered by
Ann Keen
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
17 April 2009
For answer on
21 April 2009
Answered on
23 April 2009
As soon as a patient is identified as an MRSA (methicillin-resistant Staphylococcus aureus) carrier, a decolonisation regimen should be started. This is normally the use of an antibacterial shampoo and body wash daily, and the application of an antibacterial nasal cream three times a day for five days supplied by the national health service.It is for clinicians to decide on the most appropriate products for decolonisation and we do not collect information on the products used. However, the Department will be issuing guidance on products for decontamination later this year.The current policy is to screen all elective patients, except for those in certain groups for whom the risk of MRSA infection is very low. We estimated that this would require around 6.3 million tests in 2009-10. Elective patients found to be positive for MRSA will receive decolonisation treatment. The total cost of screening those patients, and decolonising those with a positive screen, is estimated at £44 million, an average of £7.02 per patient.
Subjects
MRSA
Date
23 April 2009
Reference
491 c835-6W; 269986
House
House of Commons
(3) how many pre-operative patients he expects to be screened by the NHS for MRSA in the next 12 months; what estimate he has made of the cost per patient of such screening; and if he will make a statement.
(3) how many pre-operative patients he expects to be screened by the NHS for MRSA in the next 12 months; what estimate he has made of the cost per patient of such screening; and if he will make a statement.
Asked by
Mike Hancock
(Liberal Democrat)
Answered by
Ann Keen
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
17 April 2009
For answer on
21 April 2009
Answered on
23 April 2009
As soon as a patient is identified as an MRSA (methicillin-resistant Staphylococcus aureus) carrier, a decolonisation regimen should be started. This is normally the use of an antibacterial shampoo and body wash daily, and the application of an antibacterial nasal cream three times a day for five days supplied by the national health service.It is for clinicians to decide on the most appropriate products for decolonisation and we do not collect information on the products used. However, the Department will be issuing guidance on products for decontamination later this year.The current policy is to screen all elective patients, except for those in certain groups for whom the risk of MRSA infection is very low. We estimated that this would require around 6.3 million tests in 2009-10. Elective patients found to be positive for MRSA will receive decolonisation treatment. The total cost of screening those patients, and decolonising those with a positive screen, is estimated at £44 million, an average of £7.02 per patient.
Subjects
MRSA
Date
23 April 2009
Reference
491 c835-6W; 269987
House
House of Commons
To ask the Secretary of State for Health (1) why MRSA is not a recognised cause of death; and if he will make a statement;
To ask the Secretary of State for Health (1) why MRSA is not a recognised cause of death; and if he will make a statement;
Asked by
Mike Hancock
(Liberal Democrat)
Answered by
Angela Eagle
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
13 July 2007
For answer on
17 July 2007
Answered on
23 July 2007
I have been asked to reply.The information requested falls within the responsibility of the National Statistician, who has been asked to reply.Letter from Colin Mowl, dated 23 July 2007:"The National Statistician has been asked to reply to your questions asking why MRSA is not a recognised cause of death and whether it will be policy to adopt the recommendations of the (a) World Health Organisation and (b) Office of National Statistics and allow MRSA to be cited on a death certificate as a contributory factor. I am replying in her absence. (150539, 150538)""Diseases caused by infection with Meticillin Resistant Staphylococcus Aureus bacteria (eg MRSA septicaemia, MRSA pneumonia, MRSA wound infection etc) are recognised as causes of death and can be cited on death certificates. The Office for National Statistics publishes annual statistics on deaths certified as due to or contributed to by MRSA.""The World Health Organisation (WHO) makes recommendations, in the International Classification of Diseases, currently in its tenth revision (ICD-10), on certification of cause of death by doctors, coding and classification of diseases, and selection of a single cause for each death for statistical purposes. The General Register Office and ONS follow ICD-10 recommendations and go further, as explained below.""Doctors have a statutory duty, under the Births and Deaths Registration Act 1953, to certify the cause of death to the best of their knowledge and belief. GRO produces books of Medical Certificates of Cause of Death (MCCDs), in the format recommended by WHO, and supplies these to doctors through local registrars of births and deaths. The books include notes to doctors, based on ICD-10, on how to complete the MCCD. These ask the doctor to describe the sequence of illnesses or events that led directly to death in part I of the MCCD, ending on the last used line with the underlying cause of death. The underlying cause is defined by WHO as the disease or (external cause of) injury that initiated the morbid train of events leading directly to death. Certifiers are also asked to write in part II of the certificate any other conditions which contributed to the death but were not part of the direct sequence. WHO makes clear that the certifying doctor must use his/her clinical judgement to decide which of the conditions present at or before death contributed to the death and so should be included on the certificate.""In addition to the notes in the front of every book of MCCDs, the ONS Death Certification Advisory Group (DCAG) published updated guidance to certifiers in ACP News and on the GRO website (www.gro.gov.uk/medcert/) in June 2005. This guidance, which is also supplied to doctors with every new book of MCCDs, includes specific advice about certifying deaths involving health care associated infections (HCAI). The Department of health’s Chief Medical Officer, Sir Liam Donaldson, in his ‘CMO Update’ no 42 of July 2005, which is sent to all registered doctors, drew attention to the DCAG guidance in a short article entitled ‘Certifying deaths involving MRSA’ http://www.dh.gov.uk/en/PublicationsAndStatistics/LettersAndCirculars/CMOUpdate/DH__4115663). These publications, from ONS/GRO and the Department of Health, make absolutely clear that doctors should include MRSA and other HCAI on the death certificate in the appropriate place if they believe that the infection was part of the direct causal sequence or contributed to the death.""WHO recommends that the underlying cause of death is tabulated for routine mortality statistics because preventing it would prevent not just the death, but the whole period of illness leading up to death and so result in the greatest health gain. MRSA infection is often associated with health care, and so it will not usually be the underlying cause of death, which may be the disease or injury necessitating the care during which the MRSA infection was acquired. Because of the public, policy, professional and media interest in the subject of MRSA infection, ONS provides more than just routine underlying cause statistics. Using ICD-10 codes and the full text from MCCDs, ONS publishes annual figures on the number of deaths in which MRSA was mentioned anywhere on the death certificate, in addition to those where it was selected as the underlying cause of death. Figures for 2001 to 2005 were published in Health Statistics Quarterly no 33, which is available in the House of Commons library, in February 2007. Statistics based on death certificates which cited MRSA have also been quoted in answer to a number of previous Parliamentary questions and published in Hansard. In 2005 there were 1,629 death certificates that cited MRSA in England and Wales and in 29% of these (467 deaths) MRSA was the underlying cause of death."
Subjects
MRSA
Date
23 July 2007
Reference
463 c819-21W; 150538
House
House of Commons
(2) if he will make it his policy to adopt the recommendations of the (a) World Health Organisation and (b) Office of National Statistics and allow MRSA to be cited on a death certificate as a contributory factor.
(2) if he will make it his policy to adopt the recommendations of the (a) World Health Organisation and (b) Office of National Statistics and allow MRSA to be cited on a death certificate as a contributory factor.
Asked by
Mike Hancock
(Liberal Democrat)
Answered by
Angela Eagle
(Labour)
Answering body
Treasury
Type
Written questions
Status
Answered
Tabled on
13 July 2007
For answer on
17 July 2007
Answered on
23 July 2007
I have been asked to reply.The information requested falls within the responsibility of the National Statistician, who has been asked to reply.Letter from Colin Mowl, dated 23 July 2007:"The National Statistician has been asked to reply to your questions asking why MRSA is not a recognised cause of death and whether it will be policy to adopt the recommendations of the (a) World Health Organisation and (b) Office of National Statistics and allow MRSA to be cited on a death certificate as a contributory factor. I am replying in her absence. (150539, 150538)""Diseases caused by infection with Meticillin Resistant Staphylococcus Aureus bacteria (eg MRSA septicaemia, MRSA pneumonia, MRSA wound infection etc) are recognised as causes of death and can be cited on death certificates. The Office for National Statistics publishes annual statistics on deaths certified as due to or contributed to by MRSA.""The World Health Organisation (WHO) makes recommendations, in the International Classification of Diseases, currently in its tenth revision (ICD-10), on certification of cause of death by doctors, coding and classification of diseases, and selection of a single cause for each death for statistical purposes. The General Register Office and ONS follow ICD-10 recommendations and go further, as explained below.""Doctors have a statutory duty, under the Births and Deaths Registration Act 1953, to certify the cause of death to the best of their knowledge and belief. GRO produces books of Medical Certificates of Cause of Death (MCCDs), in the format recommended by WHO, and supplies these to doctors through local registrars of births and deaths. The books include notes to doctors, based on ICD-10, on how to complete the MCCD. These ask the doctor to describe the sequence of illnesses or events that led directly to death in part I of the MCCD, ending on the last used line with the underlying cause of death. The underlying cause is defined by WHO as the disease or (external cause of) injury that initiated the morbid train of events leading directly to death. Certifiers are also asked to write in part II of the certificate any other conditions which contributed to the death but were not part of the direct sequence. WHO makes clear that the certifying doctor must use his/her clinical judgement to decide which of the conditions present at or before death contributed to the death and so should be included on the certificate.""In addition to the notes in the front of every book of MCCDs, the ONS Death Certification Advisory Group (DCAG) published updated guidance to certifiers in ACP News and on the GRO website (www.gro.gov.uk/medcert/) in June 2005. This guidance, which is also supplied to doctors with every new book of MCCDs, includes specific advice about certifying deaths involving health care associated infections (HCAI). The Department of health’s Chief Medical Officer, Sir Liam Donaldson, in his ‘CMO Update’ no 42 of July 2005, which is sent to all registered doctors, drew attention to the DCAG guidance in a short article entitled ‘Certifying deaths involving MRSA’ http://www.dh.gov.uk/en/PublicationsAndStatistics/LettersAndCirculars/CMOUpdate/DH__4115663). These publications, from ONS/GRO and the Department of Health, make absolutely clear that doctors should include MRSA and other HCAI on the death certificate in the appropriate place if they believe that the infection was part of the direct causal sequence or contributed to the death.""WHO recommends that the underlying cause of death is tabulated for routine mortality statistics because preventing it would prevent not just the death, but the whole period of illness leading up to death and so result in the greatest health gain. MRSA infection is often associated with health care, and so it will not usually be the underlying cause of death, which may be the disease or injury necessitating the care during which the MRSA infection was acquired. Because of the public, policy, professional and media interest in the subject of MRSA infection, ONS provides more than just routine underlying cause statistics. Using ICD-10 codes and the full text from MCCDs, ONS publishes annual figures on the number of deaths in which MRSA was mentioned anywhere on the death certificate, in addition to those where it was selected as the underlying cause of death. Figures for 2001 to 2005 were published in Health Statistics Quarterly no 33, which is available in the House of Commons library, in February 2007. Statistics based on death certificates which cited MRSA have also been quoted in answer to a number of previous Parliamentary questions and published in Hansard. In 2005 there were 1,629 death certificates that cited MRSA in England and Wales and in 29% of these (467 deaths) MRSA was the underlying cause of death."
Subjects
MRSA
Date
23 July 2007
Reference
150539; 463 c819-21W
House
House of Commons
To ask the Secretary of State for Defence how many members of the armed forces have contracted MRSA in each of the last three years; where the infection is believed to have been contracted in each case; and what the cause is believed to have been in each case.
To ask the Secretary of State for Defence how many members of the armed forces have contracted MRSA in each of the last three years; where the infection is believed to have been contracted in each case; and what the cause is believed to have been in each case.
Asked by
Mike Hancock
(Liberal Democrat)
Answered by
Lord Touhig
(Labour)
Answering body
Ministry of Defence
Type
Written questions
Status
Answered
Tabled on
13 March 2006
For answer on
15 March 2006
Answered on
20 March 2006
The Ministry of Defence does not collate information on how many Service personnel have contracted MRSA. Furthermore, MRSA is not a statutorily notifiable disease, and therefore not all cases of MRSA among Service personnel will necessarily be known about by the Defence Medical Services.I refer the hon Member to the answer I gave on 28 June 2005, Official Report, column 1398W,the hon. Member for Hornsey and Wood Green (Lynne Featherstone) to the hon Member for Hornsey and Wood Green (Lynne Featherstone).
Subjects
Armed forces; MRSA
Date
20 March 2006
Reference
444 c18W;444 c18W; 59066
House
House of Commons
To ask the Secretary of State for Health how many MRSA cases there were in (a) Royal Surrey and (b) Frimley Park hospital in Surrey in each of the last three years.
To ask the Secretary of State for Health how many MRSA cases there were in (a) Royal Surrey and (b) Frimley Park hospital in Surrey in each of the last three years.
Asked by
Mike Hancock
(Liberal Democrat)
Answered by
Caroline Flint
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
8 March 2006
For answer on
10 March 2006
Answered on
14 March 2006
The information for methicillin resistant Staphylococcus aureus”” (MRSA) figures at Frimley Park hospital and Royal Surrey county hospital for each of the last three years is shown in the table.
| Last six months | ||||
| Trust name | April 2002-March 2003 | April 2003-March 2004 | April 2004-March 2005 | April 2005-September 2005 |
| Frimley Park hospital | 35 | 49 | 29 | 14 |
| Royal Surrey county hospital | 35 | 28 | 26 | 14 |
| Source: MRSA mandatory surveillance. Data was produced by the Health Protection Agency Communicable Disease Surveillance Centre for the Department of Health. |
Subjects
MRSA; Surrey
Date
14 March 2006
Reference
58320; 443 c2196W;443 c2196W
House
House of Commons
To ask the Secretary of State for Health how many MSRA cases there were in each hospital in (a) Hampshire and (b) out-of-county hospitals which receive significant numbers of patients from Hampshire in each of the last three years; and if she will make a statement.
To ask the Secretary of State for Health how many MSRA cases there were in each hospital in (a) Hampshire and (b) out-of-county hospitals which receive significant numbers of patients from Hampshire in each of the last three years; and if she will make a statement.
Asked by
Mike Hancock
(Liberal Democrat)
Answered by
Caroline Flint
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
15 February 2006
For answer on
27 February 2006
Answered on
1 March 2006
The best available information is from the mandatory methicillin resistant Staphylococcus aureus (MRSA) blood stream infections surveillance which started in April 2001 and covers acute trusts in England. The number of reported MRSA blood stream infections for acute trusts within Hampshire is shown in the table. The table also includes the Salisbury Healthcare National Health Service Trust which receives out-of-county patients from Hampshire.
| Number of reported blood stream infections (bacteraemias) | |||
|---|---|---|---|
| NHS trust | April 2002 to March 2003 | April 2003 to March 2004 | April 2004 to March 2005 |
| North Hampshire Hospitals NHS Trust | 13 | 20 | 13 |
| Isle of Wight Healthcare NHS Trust | 16 | 8 | 15 |
| Portsmouth Hospitals NHS Trust | 105 | 105 | 95 |
| Southampton University Hospitals NHS Trust | 53 | 62 | 75 |
| Winchester and Eastleigh Healthcare NHS Trust | 13 | 18 | 15 |
| Salisbury Healthcare NHS Trust | 17 | 21 | 13 |
| Source: Health Protection Agency |
Subjects
Hospitals; MRSA; Hampshire
Date
1 March 2006
Reference
443 c764W;443 c764W; 53653
House
House of Commons
To ask the Secretary of State for Health, how many people in each of the last two years have fallen ill owing to MRSA-related conditions contracted as a result of a stay in hospital in each health service area. - Inc table.
To ask the Secretary of State for Health, how many people in each of the last two years have fallen ill owing to MRSA-related conditions contracted as a result of a stay in hospital in each health service area. - Inc table.
Asked by
Mike Hancock
(Liberal Democrat)
Answered by
Melanie Johnson
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
4 June 2004
For answer on
16 June 2004
Answered on
16 June 2004
Mr. Hancock: To ask the Secretary of State for Health how many people in each of the last two years have fallen ill owing to
MRSA-related conditions contracted as a result of a stay in hospital in each health service area. [177721]
Miss Melanie Johnson: This information is not collected centrally. Available data from the national mandatory methicillin resistant
Staphylococcus aureus (MRSA) blood stream infections (bacteraemias) system is shown in the table.
Mandatory methicillin resistant Staphylococcus aureus (MRSA) blood stream infections (bacteraemias)
_________________________________________________________________________________________________.
Strategic health authority April 2002- March 2003 April 2003- March 20041
Avon, Gloucestershire and Wiltshire 389 344
Bedfordshire and Hertfordshire 173 148
Birmingham and the Black Country 455 440
Cheshire and Merseyside 344 320
County Durham and Tees Valley 155 122
Coventry, Warwickshire, Herefordshire and 182 202
Worcestershire
Cumbria and Lancashire 215 235
Dorset and Somerset 139 100
Essex 149 148
Greater Manchester 375 410
Hampshire and Isle of Wight 200 213
Kent and Medway 200 203
Leicestershire, Northamptonshire and Rutland 189 182
Norfolk, Suffolk and Cambridgeshire 392 388
North and East Yorkshire and Northern 151 197
Lincolnshire
North Central London 376 364
North East London 246 253
North West London 387 376
Northumberland, Tyne and Wear 225 267
Shropshire and Staffordshire 175 240
South East London 406 397
South West London 244 267
South West Peninsula 210 259
South Yorkshire 156 198
Surrey and Sussex 346 383
Thames Valley 243 262
Trent 305 337
West Yorkshire 357 392
_________________________________________________________________________________________________.
1 These data are provisional. Source: Health Protection Agency
Subjects
Hospitals; Infectious diseases; Health authorities; Patients; MRSA
Date
16 June 2004
Reference
177721; 422 c1005-6W
House
House of Commons
That this House notes that hospitals in England and Wales voluntarily reported 2,364 incidents of MRSA in 1997, compared with just 342 reported incidents in 1992; notes that MRSA is not a notifiable disease and that, where individual hospitals record infection with MRSA by case, these figures are likely to be much higher; believes that the Government must take urgent measures to limit the further development of these resistant strains; and calls on the Government to publish all research on MRSA carried out so far, and in particular to publish their response to the House of Lords Science and Technology Committee Report, Resistance to Antibiotics and other antimicrobial agents, as soon as possible.
That this House notes that hospitals in England and Wales voluntarily reported 2,364 incidents of MRSA in 1997, compared with just 342 reported incidents in 1992; notes that MRSA is not a notifiable disease and that, where individual hospitals record infection with MRSA by case, these figures are likely to...
Primary sponsor
David Rendel
(Liberal Democrat)
Type
Early day motions
Subjects
Hospitals; Infectious diseases; MRSA
Date
16 December 1998
Reference
147
House
House of Commons